...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: OTC Expert & Grey Market Restrictions

The thing is, Zenith CC does publically disclose financial and other information on SEDAR if that is the only issue with regards to Rule 15c2-11

https://www.gibsondunn.com/wp-content/uploads/2022/11/recent-sec-interpretation-of-exchange-act-rule-15c2-11-may-pressure-private-issuers-of-fixed-income-securities-to-publicly-disclose-financial-information.pdf

 

Koo 

Share
New Message
Please login to post a reply